Breaking News Instant updates and real-time market news.

SSTK

Shutterstock

$59.37 /

+0.35 (+0.59%)

07:06
07/07/22
07/07
07:06
07/07/22
07:06

Shutterstock joins the board of the News Media Coalition

Shutterstock announced that it has joined the News Media Coalition, NMC, an international industry organization comprising global news brands, including major news publishers and news agencies. The membership marks a meaningful step for Shutterstock and its Editorial business. Shutterstock Editorial is committed to supporting a free press that allows journalists and contributors to report editorially on events around the world without arbitrary restriction. Additionally, the Editorial business has exclusive content partnerships with Conde Nast, 'epa', the LIFE Picture Collection, AP and A+E, as well as a significant presence at global events, including the English Premier League, the Screen Actors Guild Awards, the Academy Awards, the BAFTA's and more. Andrew Moger, Chief Executive Officer at News Media Coalition, said: "The NMC is the only international news industry body operating in this area. As we grow influence and success, we are delighted to have Shutterstock involved and supporting our mission. We know, like other major news brands in our membership, Shutterstock will bring a wealth of expertise and industry knowledge to the NMC. Shutterstock joins our board at a time when a free press is more important than ever. We look forward to working together on important policy issues, upholding and sharing our values of integrity and transparency and journalistic independence."

  • 26

    Jul

OTHER BREAKING NEWS FROM THE FLY

Recommendations
ShockWave Medical price target raised to $255 from $176 at Wells Fargo » 06:52
08/09/22
08/09
06:52
08/09/22
06:52
SWAV

ShockWave Medical

$221.92 /

-0.94 (-0.42%)

Wells Fargo analyst Larry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

04:53 Today Piper Sandler
ShockWave Medical price target raised to $278 from $245 at Piper Sandler
05/23/22 Piper Sandler
ShockWave Medical's China approval adds growth driver, says Piper Sandler
05/10/22 Canaccord
ShockWave Medical price target lowered to $190 from $221 at Canaccord
05/10/22 Wells Fargo
ShockWave Medical price target lowered to $176 from $235 at Wells Fargo
SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

Hot Stocks
Moderna amends Covid-19 vaccine agreement with EC » 06:52
08/09/22
08/09
06:52
08/09/22
06:52
MRNA

Moderna

$183.08 /

-3.71 (-1.99%)

Moderna announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

06/29/22 Evercore ISI
Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data
06/14/22 Piper Sandler
Piper Sandler confident in positive VRBPAC opinion for Moderna's SpikeVax
06/13/22 Morgan Stanley
Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
05/17/22 Piper Sandler
Moderna price target lowered to $214 from $348 at Piper Sandler
MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

Earnings
International Seaways reports Q2 adjusted EPS $1.43, consensus $1.19 » 06:51
08/09/22
08/09
06:51
08/09/22
06:51
INSW

International Seaways

$25.40 /

+0.61 (+2.46%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INSW International Seaways
$25.40 /

+0.61 (+2.46%)

INSW International Seaways
$25.40 /

+0.61 (+2.46%)

07/27/22 BTIG
International Seaways upgraded to Buy from Neutral at BTIG
07/20/22 Jefferies
International Seaways initiated with a Buy at Jefferies
07/19/22 Stifel
International Seaways price target raised to $31 from $27 at Stifel
07/06/22 B. Riley
Tanker stocks have more room to run, says B. Riley
INSW International Seaways
$25.40 /

+0.61 (+2.46%)

INSW International Seaways
$25.40 /

+0.61 (+2.46%)

Downgrade
Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo » 06:50
08/09/22
08/09
06:50
08/09/22
06:50
GBT

Global Blood Therapeutics

$66.58 /

+2.77 (+4.34%)

, PFE

Pfizer

$49.55 /

+0.29 (+0.59%)

Wells Fargo analyst Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
08/08/22 RBC Capital
Global Blood downgraded to Sector Perform from Outperform at RBC Capital
08/08/22 Cowen
Global Blood Therapeutics downgraded to Market Perform from Outperform at Cowen
08/08/22 Guggenheim
Global Blood Therapeutics downgraded to Neutral from Buy at Guggenheim
PFE Pfizer
$49.55 /

+0.29 (+0.59%)

08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
08/08/22 Oppenheimer
Global Blood Therapeutics downgraded to Perform from Outperform at Oppenheimer
08/08/22 Stifel
Global Blood Therapeutics downgraded to Hold from Buy at Stifel
08/08/22 Piper Sandler
Global Blood takeover by Pfizer 'solid outcome,' says Piper Sandler
GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

Earnings
IAA reports Q2 adjusted EPS 62c, consensus 57c » 06:50
08/09/22
08/09
06:50
08/09/22
06:50
IAA

IAA

$38.26 /

+0.54 (+1.43%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IAA IAA
$38.26 /

+0.54 (+1.43%)

IAA IAA
$38.26 /

+0.54 (+1.43%)

06/09/22 Guggenheim
IAA upgraded to Buy from Neutral at Guggenheim
05/10/22 Barrington
IAA upgraded to Outperform at Barrington after better-than-expected Q1
05/10/22 Barrington
IAA upgraded to Outperform from Market Perform at Barrington
03/15/22 Stephens
Stephens agrees with activist that IAA undervalued
IAA IAA
$38.26 /

+0.54 (+1.43%)

Earnings
Target Hospitality reports Q2 EPS 24c, consensus 17c » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
TH

Target Hospitality

$13.97 /

+0.12 (+0.87%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

07/12/22 Oppenheimer
Target Hospitality price target raised to $18 from $9 at Oppenheimer
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

Recommendations
Enanta price target raised to $137 from $103 at JMP Securities » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
ENTA

Enanta

$71.21 /

+0.39 (+0.55%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

ENTA Enanta
$71.21 /

+0.39 (+0.55%)

08/01/22 Oppenheimer
Enanta price target raised to $53 from $45 at Oppenheimer
07/29/22 Piper Sandler
Enanta's 'strong' EDP-235 data supports 'impressive' profile, says Piper Sandler
07/06/22 Evercore ISI
Enanta upgraded to Outperform at Evercore ISI ahead of COVID anti-viral data
07/06/22 Evercore ISI
Enanta upgraded to Outperform from In Line at Evercore ISI
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

ENTA Enanta
$71.21 /

+0.39 (+0.55%)

Earnings
Capri Holdings sees FY23 EPS $6.85, consensus $6.74 » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
CPRI

Capri Holdings

$51.01 /

+1.38 (+2.78%)

Sees FY23 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/28/22 Barclays
Capri Holdings price target raised to $66 from $63 at Barclays
07/21/22 Credit Suisse
Capri Holdings price target lowered to $56 from $65 at Credit Suisse
07/21/22 Goldman Sachs
Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
07/15/22 UBS
Capri Holdings price target lowered to $65 from $91 at UBS
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

Recommendations
Tyson Foods price target lowered to $95 from $100 at Stephens » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
TSN

Tyson Foods

$80.10 /

-7.395 (-8.45%)

Stephens analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

06:16 Today BMO Capital
Tyson Foods price target lowered to $90 from $99 at BMO Capital
05:55 Today Barclays
Tyson Foods price target lowered to $89 from $100 at Barclays
04:57 Today Piper Sandler
Piper upgrades Tyson Foods to Neutral with risks priced in
08/08/22 Piper Sandler
Tyson Foods upgraded to Neutral from Underweight at Piper Sandler
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

Recommendations
Reata Pharmaceuticals price target lowered to $27 from $37 at Baird » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
RETA

Reata Pharmaceuticals

$24.02 /

-11.895 (-33.12%)

Baird analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

08/08/22 Goldman Sachs
Reata sinks on Friedreich's ataxia update but Goldman remains positive
08/08/22 Goldman Sachs
Reata Pharmaceuticals price target raised to $76 from $73 at Goldman Sachs
05/27/22 Citi
Reata Pharmaceuticals price target raised to $46 from $43 at Citi
05/11/22 Ladenburg
Reata Pharmaceuticals price target lowered to $67 from $75 at Ladenburg
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

Hot Stocks
Wireless Telecom sees Q3 bookings $8M-$10M » 06:48
08/09/22
08/09
06:48
08/09/22
06:48
WTT

Wireless Telecom

$1.56 /

+0.08 (+5.41%)

Tim Whelan, CEO of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

Earnings
Capri Holdings reports Q1 adjusted EPS $1.50, consensus $1.36 » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
CPRI

Capri Holdings

$51.01 /

+1.38 (+2.78%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/28/22 Barclays
Capri Holdings price target raised to $66 from $63 at Barclays
07/21/22 Credit Suisse
Capri Holdings price target lowered to $56 from $65 at Credit Suisse
07/21/22 Goldman Sachs
Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
07/15/22 UBS
Capri Holdings price target lowered to $65 from $91 at UBS
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

Hot Stocks
Planet Fitness announces Jamie Medeiros as chief brand officer » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
PLNT

Planet Fitness

$81.08 /

+0.71 (+0.88%)

Planet Fitness announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

07/07/22 Exane BNP Paribas
Planet Fitness upgraded to Neutral from Underperform at Exane BNP Paribas
06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
06/07/22 Cowen
Planet Fitness positioned to succeed despite macro challenges, says Cowen
05/25/22 Cowen
Planet Fitness operating model remains resilient among headwinds, says Cowen
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

Recommendations
Mersana Therapeutics price target raised to $20 from $18 at Baird » 06:47
08/09/22
08/09
06:47
08/09/22
06:47
MRSN

Mersana Therapeutics

$5.24 /

+0.215 (+4.28%)

, GSK

GSK plc

$40.31 /

-0.27 (-0.67%)

Baird analyst Collen Kusy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

05/10/22 Baird
Mersana Therapeutics price target lowered to $18 from $23 at Baird
05/09/22 H.C. Wainwright
Mersana price target lowered to $19 from $24 at H.C. Wainwright
11/10/21 Baird
Mersana Therapeutics price target lowered to $23 from $30 at Baird
10/14/21 BTIG
Mersana Therapeutics assumed with a Buy at BTIG
GSK GSK plc
$40.31 /

-0.27 (-0.67%)

08/08/22 UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
08/05/22 Morgan Stanley
GSK plc resumed with an Equal Weight at Morgan Stanley
07/21/22 Citi
GSK plc resumed with a Neutral at Citi
07/20/22 UBS
GSK plc price target lowered to 1,850 GBp from 1,876 GBp at UBS
MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

MRSN Mersana Therapeutics
$5.24 /

+0.215 (+4.28%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

GSK GSK plc
$40.31 /

-0.27 (-0.67%)

Earnings
Wireless Telecom reports Q2 cont ops EPS (6c), consensus (4c) » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
WTT

Wireless Telecom

$1.56 /

+0.08 (+5.41%)

Reports Q2 revenue $6.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

WTT Wireless Telecom
$1.56 /

+0.08 (+5.41%)

Recommendations
Scholar Rock price target lowered to $43 from $55 at BMO Capital » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
SRRK

Scholar Rock

$8.54 /

+0.035 (+0.41%)

BMO Capital analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

07/12/22 Truist
Scholar Rock initiated with a Buy at Truist
06/23/22 Piper Sandler
Scholar Rock price target lowered to $19 from $28 at Piper Sandler
05/24/22 JPMorgan
Scholar Rock price target lowered to $37 from $46 at JPMorgan
05/17/22 BMO Capital
Scholar Rock price target lowered to $55 from $74 at BMO Capital
SRRK Scholar Rock
$8.54 /

+0.035 (+0.41%)

Hot Stocks
Hormel Foods announces new operating model » 06:46
08/09/22
08/09
06:46
08/09/22
06:46
HRL

Hormel Foods

$49.03 /

+0.105 (+0.21%)

Hormel Foods announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

03/15/22 Goldman Sachs
Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
03/10/22 Argus
Hormel Foods upgraded to Buy at Argus on pricing power
03/10/22 Argus
Hormel Foods upgraded to Buy from Hold at Argus
01/25/22 Piper Sandler
Hormel Foods price target lowered to $48 from $49 at Piper Sandler
HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

HRL Hormel Foods
$49.03 /

+0.105 (+0.21%)

Downgrade
Nike downgraded to Neutral at Exane BNP Paribas on concerns about FY25 targets » 06:44
08/09/22
08/09
06:44
08/09/22
06:44
NKE

Nike

$114.01 /

+0.13 (+0.11%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$114.01 /

+0.13 (+0.11%)

NKE Nike
$114.01 /

+0.13 (+0.11%)

05:30 Today Exane BNP Paribas
Nike downgraded to Neutral from Outperform at Exane BNP Paribas
07/25/22 Piper Sandler
Nike assumed with a Neutral at Piper Sandler
07/21/22 KeyBanc
KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view
07/20/22 KeyBanc
Nike initiated with a Sector Weight at KeyBanc
NKE Nike
$114.01 /

+0.13 (+0.11%)

NKE Nike
$114.01 /

+0.13 (+0.11%)

NKE Nike
$114.01 /

+0.13 (+0.11%)

NKE Nike
$114.01 /

+0.13 (+0.11%)

Earnings
Vivid Seats raises FY22 revenue view to $540.0M-$570.0M from $520.0M-$555.0M » 06:44
08/09/22
08/09
06:44
08/09/22
06:44
SEAT

Vivid Seats

$8.70 /

+0.18 (+2.11%)

Consensus is for FY22…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

07/14/22 Piper Sandler
Vivid Seats initiated with a Neutral at Piper Sandler
07/07/22 Citi
Vivid Seats price target lowered to $12 from $14 at Citi
05/10/22 Raymond James
Vivid Seats price target lowered to $11 from $17 at Raymond James
03/11/22 Benchmark
Vivid Seats price target lowered to $17 from $19 at Benchmark
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

Recommendations
Castle Biosciences price target raised to $48 from $44 at Baird » 06:44
08/09/22
08/09
06:44
08/09/22
06:44
CSTL

Castle Biosciences

$28.33 /

-2.34 (-7.63%)

Baird analyst Catherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

05/19/22 Baird
Baird says final LCD for test 'incrementally positive' for Castle Biosciences
05/10/22 Canaccord
Castle Biosciences price target lowered to $65 from $80 at Canaccord
05/10/22 Baird
Castle Biosciences price target lowered to $44 from $50 at Baird
05/09/22 BTIG
Castle Biosciences transferred with a Buy at BTIG
CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

CSTL Castle Biosciences
$28.33 /

-2.34 (-7.63%)

Hot Stocks
Nielsen postpones court, special meeting regarding acquisition by consortium » 06:43
08/09/22
08/09
06:43
08/09/22
06:43
NLSN

Nielsen

$22.71 /

-0.33 (-1.43%)

Nielsen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

05/16/22 BMO Capital
Nielsen downgraded to Market Perform from Outperform at BMO Capital
03/30/22 Jefferies
Nielsen downgraded to Hold from Buy at Jefferies
03/29/22 Morgan Stanley
Morgan Stanley raises Nielsen to Equal Weight, says 'may be better off private'
03/29/22 Morgan Stanley
Nielsen upgraded to Equal Weight from Underweight at Morgan Stanley
NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

NLSN Nielsen
$22.71 /

-0.33 (-1.43%)

Earnings
Hain Celestial sees FY23 low single digit adjusted net sales growth » 06:43
08/09/22
08/09
06:43
08/09/22
06:43
HAIN

Hain Celestial

$23.08 /

+0.1 (+0.44%)

FY23 outlook: The company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAIN Hain Celestial
$23.08 /

+0.1 (+0.44%)

06/16/22 Piper Sandler
Hain Celestial price target lowered to $31 from $36 at Piper Sandler
05/24/22 CL King
Hain Celestial initiated with a Buy at CL King
05/23/22 Cowen
Hain Celestial initiated with an Outperform at Cowen
05/09/22 Mizuho
Hain Celestial price target lowered to $31 from $44 at Mizuho
HAIN Hain Celestial
$23.08 /

+0.1 (+0.44%)

  • 11
    Nov
Recommendations
Targa Resources price target raised to $91 from $87 at Mizuho » 06:42
08/09/22
08/09
06:42
08/09/22
06:42
TRGP

Targa Resources

$65.03 /

+1.275 (+2.00%)

Mizuho analyst Gabriel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

07/20/22 Barclays
Targa Resources price target lowered to $87 from $92 at Barclays
07/12/22 RBC Capital
Targa Resources price target raised to $100 from $90 at RBC Capital
05/02/22 Truist
Targa Resources assumed with a Buy at Truist
04/26/22 Morgan Stanley
Targa Resources price target raised to $103 from $74 at Morgan Stanley
TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

TRGP Targa Resources
$65.03 /

+1.275 (+2.00%)

Earnings
Vivid Seats reports Q2 rvenue $147.7M, consensus $125.4M » 06:42
08/09/22
08/09
06:42
08/09/22
06:42
SEAT

Vivid Seats

$8.70 /

+0.18 (+2.11%)

Reports Q2 Adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

07/14/22 Piper Sandler
Vivid Seats initiated with a Neutral at Piper Sandler
07/07/22 Citi
Vivid Seats price target lowered to $12 from $14 at Citi
05/10/22 Raymond James
Vivid Seats price target lowered to $11 from $17 at Raymond James
03/11/22 Benchmark
Vivid Seats price target lowered to $17 from $19 at Benchmark
SEAT Vivid Seats
$8.70 /

+0.18 (+2.11%)

Recommendations
Pinnacle West price target raised to $77 from $76 at Mizuho » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
PNW

Pinnacle West

$75.60 /

+0.215 (+0.29%)

Mizuho analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNW Pinnacle West
$75.60 /

+0.215 (+0.29%)

07/18/22 Barclays
Pinnacle West price target lowered to $68 from $78 at Barclays
06/30/22 UBS
Pinnacle West price target lowered to $67 from $74 at UBS
04/25/22 Credit Suisse
Pinnacle West initiated with an Underperform at Credit Suisse
04/19/22 Barclays
Pinnacle West downgraded to Underweight from Equal Weight at Barclays
PNW Pinnacle West
$75.60 /

+0.215 (+0.29%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.